{
    "clinical_study": {
        "@rank": "168045", 
        "acronym": "NPH", 
        "arm_group": [
            {
                "arm_group_label": "Methadone", 
                "arm_group_type": "Experimental", 
                "description": "in this arm patients will take methadone 5mg."
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Experimental", 
                "description": "in this arm patients will take placebo pills."
            }
        ], 
        "brief_summary": {
            "textblock": "Neuropathic pain is a common condition and affecting 40 to 70% of the general population.\n      Post-herpetic neuralgia is a condition almost complex and requires a multi modal treatment.\n      Aim: This is a pilot proof-of-principle study designed to evaluate the use of low-dose\n      methadone in post-herpetic neuralgia patients who remained refractory after first and second\n      line treatment for post-herpetic neuralgia (PHN) and had indication for the association of\n      an opioid agent to their current drug regimen."
        }, 
        "brief_title": "Methadone in Post-Herpetic Neuralgia Pain", 
        "completion_date": {
            "#text": "March 2013", 
            "@type": "Actual"
        }, 
        "condition": "Post-herpetic Neuralgia", 
        "condition_browse": {
            "mesh_term": [
                "Neuralgia", 
                "Neuralgia, Postherpetic"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients with chronic (>6 months) symptomatic PHN\n\n          -  with visual analogical scale >40/100mm\n\n          -  use of first and second line drugs (tricyclic antidepressants, venlafaxine and\n             gabapentinoids)\n\n        Exclusion Criteria:\n\n          -  Don't full the criteria above"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "10", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "December 11, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01752699", 
            "org_study_id": "NPH"
        }, 
        "intervention": [
            {
                "arm_group_label": "Methadone", 
                "description": "patients with post-herpetic neuralgia take methadone or placebo to treat pain symptoms.", 
                "intervention_name": "Methadone", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Placebo", 
                "description": "patients with post-herpetic neuralgia take placebo to treat the pain symptoms.", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Methadone"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "neuropathic pain,", 
            "post-herpetic neuralgia,", 
            "methadone,"
        ], 
        "lastchanged_date": "March 14, 2013", 
        "number_of_arms": "2", 
        "official_title": "Methadone in Post-Herpetic Neuralgia Pain", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Brazil: Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "February 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Assessing by verbal analog scale (VAS)", 
            "measure": "Change in baseline Pain", 
            "safety_issue": "No", 
            "time_frame": "baseline (visit inclusion) and three moths latter"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01752699"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Sao Paulo", 
            "investigator_full_name": "Daniel Ciampi Araujo de Andrade", 
            "investigator_title": "MD, PhD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "University of Sao Paulo", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Sao Paulo", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 1998", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2013"
    }
}